BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34142311)

  • 1. 2-D08 treatment regulates C2C12 myoblast proliferation and differentiation via the Erk1/2 and proteasome signaling pathways.
    Liu H; Lee SM; Joung H
    J Muscle Res Cell Motil; 2021 Jun; 42(2):193-202. PubMed ID: 34142311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubc9 expression is essential for myotube formation in C2C12.
    Riquelme C; Barthel KK; Qin XF; Liu X
    Exp Cell Res; 2006 Jul; 312(11):2132-41. PubMed ID: 16631162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation.
    Contreras O; Villarreal M; Brandan E
    Skelet Muscle; 2018 Feb; 8(1):5. PubMed ID: 29463296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 Induces Myogenic Differentiation via JAK2-STAT3 Signaling in Mouse C2C12 Myoblast Cell Line and Primary Human Myoblasts.
    Steyn PJ; Dzobo K; Smith RI; Myburgh KH
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
    Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
    Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.
    Dogra C; Changotra H; Mohan S; Kumar A
    J Biol Chem; 2006 Apr; 281(15):10327-36. PubMed ID: 16461349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent Regulation of Myotube Formation and Gene Expression by E2 and EPA during In-Vitro Differentiation of C2C12 Myoblasts.
    Lacham-Kaplan O; Camera DM; Hawley JA
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation of histone deacetylase 1 regulates MyoD signaling during myogenesis.
    Joung H; Kwon S; Kim KH; Lee YG; Shin S; Kwon DH; Lee YU; Kook T; Choe N; Kim JC; Kim YK; Eom GH; Kook H
    Exp Mol Med; 2018 Jan; 50(1):e427. PubMed ID: 29328071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-183-5p induced by saturated fatty acids regulates the myogenic differentiation by directly targeting FHL1 in C2C12 myoblasts.
    Nguyen MT; Min KH; Lee W
    BMB Rep; 2020 Nov; 53(11):605-610. PubMed ID: 33148375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of integrin α7β1 signaling in myoblast differentiation on aligned polydioxanone scaffolds.
    McClure MJ; Clark NM; Hyzy SL; Chalfant CE; Olivares-Navarrete R; Boyan BD; Schwartz Z
    Acta Biomater; 2016 Jul; 39():44-54. PubMed ID: 27142254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Di-(2-ethylhexyl)-phthalate reduces MyoD and myogenin expression and inhibits myogenic differentiation in C2C12 cells.
    Chen SS; Hung HT; Chen TJ; Hung HS; Wang DC
    J Toxicol Sci; 2013; 38(5):783-91. PubMed ID: 24067726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium perfringens α-toxin inhibits myogenic differentiation of C2C12 myoblasts.
    Takehara M; Kobayashi K; Nagahama M
    Anaerobe; 2020 Oct; 65():102265. PubMed ID: 32860931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-proteasome-mediated degradation and synthesis of MyoD is modulated by alphaB-crystallin, a small heat shock protein, during muscle differentiation.
    Singh BN; Rao KS; Rao ChM
    Biochim Biophys Acta; 2010 Feb; 1803(2):288-99. PubMed ID: 20005263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aminopeptidase LAP3 suppression accelerates myogenic differentiation via the AKT-TFE3 pathway in C2C12 myoblasts.
    Osana S; Kitajima Y; Naoki S; Murayama K; Takada H; Tabuchi A; Kano Y; Nagatomi R
    J Cell Physiol; 2023 Sep; 238(9):2103-2119. PubMed ID: 37435895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
    Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of hypoxia-inducible factor-1alpha by siRNA inhibits C2C12 myoblast differentiation.
    Ono Y; Sensui H; Sakamoto Y; Nagatomi R
    J Cell Biochem; 2006 Jun; 98(3):642-9. PubMed ID: 16440321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts.
    Yi X; Tao Y; Lin X; Dai Y; Yang T; Yue X; Jiang X; Li X; Jiang DS; Andrade KC; Chang J
    Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):697-707. PubMed ID: 28130125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydropalmatine promotes myoblast differentiation through activation of p38MAPK and MyoD.
    Lee SJ; Yoo M; Go GY; Hwang J; Lee HG; Kim YK; Seo DW; Baek NI; Ryu JH; Kang JS; Bae GU
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):147-52. PubMed ID: 25450677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 Signaling Promotes Myoblast Differentiation and Fusion by Enhancing the Expression of MyoD, Myogenin, and Myomerger.
    Kurosaka M; Hung YL; Machida S; Kohda K
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.